Idiopathic Pulmonary Fibrosis Registry China Study (PORTRAY)

Dai Huaping

Status: Unknown

Conditions: Idiopathic Pulmonary Fibrosis

Study type: Observational

Funder types: Other

Identifiers

NCT03666234

ChinaJapanFH002

Details and patient eligibility

About

By mean of registry of newly diagnosed Chinese IPF patients from more than 15 sites, this study aims to build IPF prospective cohort, set up normative clinical database and a biological specimen bank, and examine the clinical characteristics of newly diagnosed Chinese IPF patients, as well as the nature history, prognosis, comorbidities and complications of IPF patients in China, the current treatment pattern, burden of illness, and quality of life of Chinese IPF patients.

Enrollment: 800 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Physician diagnosed IPF during the last 3 months based upon ATS/ERS/JRS/ALAT guidelines 2011
• Aged 40 years and above at recruitment
• Willing and able to sign an informed consent

Exclusion criteria

• Inclusion in any interventional clinical trials
• Lung transplantation expected within the next 6 months.